- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1750
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery ; volume:200 ; number:4 ; day:30 ; month:6 ; year:2022 ; pages:505-512 ; date:8.2022
Lung ; 200, Heft 4 (30.6.2022), 505-512, 8.2022
- Creator
-
Doerr, Fabian
Stange, Sebastian
Michel, Maximilian
Schlachtenberger, Georg
Menghesha, Hruy
Wahlers, Thorsten
Hekmat, Khosro
Heldwein, Matthias B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00408-022-00549-8
- URN
-
urn:nbn:de:101:1-2022102422573763165390
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Doerr, Fabian
- Stange, Sebastian
- Michel, Maximilian
- Schlachtenberger, Georg
- Menghesha, Hruy
- Wahlers, Thorsten
- Hekmat, Khosro
- Heldwein, Matthias B.
- SpringerLink (Online service)
Other Objects (12)
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
Redefining the role of surgery in early small-cell lung cancer
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
Redefining the role of surgery in early small-cell lung cancer
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
Redefining the role of surgery in early small-cell lung cancer
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
Target engagement imaging of PARP inhibitors in small-cell lung cancer